Abstract

Thermal processing has gained much interest in the pharmaceutical industry, particularly for the enhancement of solubility, bioavailability, and dissolution of active pharmaceutical ingredients (APIs) with poor aqueous solubility. Formulation scientists have developed various techniques which may include physical and chemical modifications to achieve solubility enhancement. One of the most commonly used methods for solubility enhancement is through the use of amorphous solid dispersions (ASDs). Examples of commercialized ASDs include Kaletra®, Kalydeco®, and Onmel®. Various technologies produce ASDs; some of the approaches, such as spray-drying, solvent evaporation, and lyophilization, involve the use of solvents, whereas thermal approaches often do not require solvents. Processes that do not require solvents are usually preferred, as some solvents may induce toxicity due to residual solvents and are often considered to be damaging to the environment. The purpose of this review is to provide an update on recent innovations reported for using hot-melt extrusion and KinetiSol® Dispersing technologies to formulate poorly water-soluble APIs in amorphous solid dispersions. We will address development challenges for poorly water-soluble APIs and how these two processes meet these challenges.

Highlights

  • It is estimated that about 40% of the drugs currently on the market and up to 70–90% of the drugs in the pharmaceutical discovery pipeline are poorly water-soluble [1,2,3]

  • When producing amorphous solid dispersions (ASDs) via hot-melt extrusion (HME), the melting point of the active pharmaceutical ingredients (APIs) often needs to be compatible with the melting point of the polymer for the successful conversion of a stable ASD

  • HME can be utilized as a reaction vessel to form co-crystals, another viable way to improve the bioavailability of poorly water-soluble APIs

Read more

Summary

Research Article

Theme: Pharmaceutical Thermal Processing - An Update Guest Editors: Feng Zhang, Michael Repka and Suresh Bandari. Received 27 June 2020; accepted 14 October 2020; published online 8 November 2020

INTRODUCTION
Amorphous Solid Dispersions
Specific Energy Impacts Crystallinity and Degradation
In Situ Salt Formation Prevents API Degradation
Venting and Solvent Assist to Prevent Hydrolysis
Hydrate Formation Decreases Processing Temperatures
Homogeneity with Very Low API Loading
Improving upon a Commercialized ASD
Expanding the Formulation Design Space of ASDs
Findings
CONCLUSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.